ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Méthergin®, solution injectable s.c., i.m., i.v.:Essential Pharma Switzerland GmbH
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
G02AB01 - MethylergometrineATC-DDD Version 2016. Source: WHO
G - Genito Urinary System and Sex Hormones
 
G02 - Other Gynecologicals

Analgesics used in dysmenorrhea, see N02B - Other analgesics and antipyretics and M01A - Antiinflammatory and antirheumatic products, non-steroids.

G02A - Uterotonics

Plain preparations of oxytocin and analogues are classified in H01B - Posterior pituitary lobe hormones.

G02AB - Ergot Alkaloids

This group comprises ergot alkaloids, e.g. methylergometrine, used for stimulation of uterine contractions. Other ergot alkaloids are classified in C04A - Peripheral vasodilators, and in N02C - Anti-migraine preparations.

The DDDs are based on use in delivery.

G02AB01 - Methylergometrine
Concentr.Adm.RouteNote
 P 
 O 
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home